La interacion entre la tylosina, sulfametacina sódica y el trimetoprim para su uso en la terapia y prevencion de enfermedades en medicina veterinaria / A interação entre tilosina, sulfametazina sódica e trimetoprim para uso na terapia e prevenção de doenças em medicina veterinária
Resumo
Palavras-chave
Texto completo:
PDFReferências
Alain L F. A Antibiotics and Antibiotic Resistance. Biomed J Sci & Tech Res. 1(1)-2017. DOI: 10.26717/BJSTR.2017.01.000117
Bennet, J. V., Brodie J. L.; Benner, E. J.,Kirby, W. M.M. 1966 Simplified, accurate method for antibiotic assay of clinical specimens. App. Microbiol. 14: 170 -177
Desbiolles, N, Piroth L, Lequeu C, Neuwirth C, Portier H, and Chavanet P. 2001. Fractional Maximal Effect Method for In Vitro Synergy between Amoxicillin and Ceftriaxone and between Vancomycin and Ceftriaxone against Enterococcus faecalis and Penicillin-Resistant Streptococcus pneumoniae.Antimicrobial Agents and Chemotherapy, December 2001, p. 3328-3333, Vol. 45, No. 12
Fuentes Hernandez, V.O.Antibioticos 2020. Farmacología Veterinaria. ISBN 970-27-0165-1 Comision Editorial. Universidad de Guadalajara
Fuentes Hernández VO 2022, “The Interactive Effect between Kitasamycin Tartrate and Doxycycline Hydrate for Use in the Therapy and Prevention of Diseases in Veterinary Medicine” RA JOURNAL OF APPLIED RESEARCH ISSN: 2394-6709 DOI:10.47191/rajar/v8i4.04 Volume: 08 Issue: 04 April-2022
Ghanemand Abu-Lafi 2015. Development and Validation of RP-HPLC Method for the Simultaneous Determination of Trimethoprim, Sulfadimidine Sodium and Tylosin Tartrate in injectable solution formulation. Journal of Applied Pharmaceutical Science 5 (01); 2015: 094-098
Hamilton-Miller, J. M. T. 1985. Rationalization of terminology and methodology in the study of antibiotic interaction. J. Antimicrob. Chemother. 15:655-658
King, T. C., D. Schlessinger, and D. J. Krogstad. 1981. The assesment of antimicrobial combinations. Rev. Infect. Dis. 3:627-633
National Committee for Clinical Laboratory Standards. 1994. Performance for antimicrobial susceptibility testing. Standard M100-S5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
Rahal, J. J. 1978. Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine 57:179-195
Ruiz, J. G. Antibioticos 2000. En Farmacología Veterinaria. Autor: Victor O. Fuentes, ISBN 970-27-0165-1 Comision Editorial de la Universidad de Guadalajara México p 60 - 150
Ulvatne, H., Karoliussen, S., Stiberg, T., Rekdal, O., Svendsen, J., 2001. Short antibacterial peptides and erythromycin act synergically against Escherichia coli. Journal of Antimicrobial Chemotherapy (2001) 48, 203-208
Vilchèze, C, and Jacobs W R Jr. 2012 “The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosis.” Antimicrobial agents and chemotherapy vol. 56,10 (2012): 5142-8. doi:10.1128/AAC.00832-12
DOI: https://doi.org/10.34188/bjaerv5n2-052
Apontamentos
- Não há apontamentos.